Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,500
Closed -$5.89M 1073
2022
Q4
$5.89M Buy
+11,500
New +$6.04M 0.03% 356

Other funds holding HUM

Natixis's HUM Position: Q1 2026 in Review

Natixis increased its Humana (HUM) stake by 276% in Q1 2026, buying an estimated $17.9M and bringing the position to 118,639 shares worth $20.6M. The position accounts for 0.07% of the portfolio, ranked #189.

Natixis first reported a position in HUM in Q4 2013 and has held it in 44 quarters since. The position peaked at $138M in Q3 2018. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Natixis held 118,639 shares of Humana worth $20.6M as of Q1 2026.
  • Natixis bought 87,101 Humana shares in Q1 2026, an estimated $17.9M.
  • Humana made up 0.07% of Natixis's portfolio in Q1 2026, its #189 holding.
  • Natixis first reported a position in Humana in Q4 2013 and has held it in 44 quarters since.
  • Natixis's Humana position peaked at $138M in Q3 2018.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.